Risk classification of clinically localized prostate cancer: Data from clinicopathological research for localized prostate cancer (CRPC)

Medicine and Dentistry

• Prostate Cancer 100%
• Patient 40%
• Diseases 40%
• High Risk Population 40%
• Intermediate Risk Population 40%
• Therapeutic Procedure 20%
• Man 20%
• Tenidap 20%
• Prostatectomy 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Prostate Cancer 100%
• Diseases 40%
• Tenidap 20%
• Clebopride 20%

Biochemistry, Genetics and Molecular Biology

• Classification 40%
• Intermediate Risk Population 40%
• High Risk Population 40%
• Aggressiveness 20%
• Disease Registry 20%